{"id":"https://openalex.org/W2087600102","doi":"https://doi.org/10.1111/j.1476-5381.1984.tb10119.x","title":"The effects of benzodiazepine agonists, inverse agonists and Ro 15\u20131788 on the responses of the superior cervical ganglion to GABA in vitro","display_name":"The effects of benzodiazepine agonists, inverse agonists and Ro 15\u20131788 on the responses of the superior cervical ganglion to GABA in vitro","publication_year":1984,"publication_date":"1984-09-01","ids":{"openalex":"https://openalex.org/W2087600102","doi":"https://doi.org/10.1111/j.1476-5381.1984.tb10119.x","mag":"2087600102","pmid":"https://pubmed.ncbi.nlm.nih.gov/6091828","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1987195"},"language":"en","primary_location":{"id":"doi:10.1111/j.1476-5381.1984.tb10119.x","doi":"https://doi.org/10.1111/j.1476-5381.1984.tb10119.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.1984.tb10119.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.1984.tb10119.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.1984.tb10119.x","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112195037","display_name":"Hilary J. Little","orcid":"https://orcid.org/0009-0005-7678-0845","observed_orcids":["https://orcid.org/0009-0005-7678-0845"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"H.J. Little","raw_affiliation_strings":["University of Oxford, Department of Pharmacology, South Parks Road, Oxford OX1 3QT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Oxford, Department of Pharmacology, South Parks Road, Oxford OX1 3QT","institution_ids":["https://openalex.org/I40120149"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5112195037"],"corresponding_institution_ids":["https://openalex.org/I40120149"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":1.8205,"has_fulltext":true,"cited_by_count":30,"citation_normalized_percentile":{"value":0.84923144,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"83","issue":"1","first_page":"57","last_page":"68"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11818","display_name":"Nicotinic Acetylcholine Receptors Study","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/benzodiazepine-receptor-agonists","display_name":"benzodiazepine receptor agonists","score":0.9470000267028809},{"id":"https://openalex.org/keywords/benzodiazepine-inverse-agonist","display_name":"benzodiazepine inverse agonist","score":0.9629999995231628},{"id":"https://openalex.org/keywords/ro-15-1788","display_name":"Ro 15-1788","score":0.9819999933242798},{"id":"https://openalex.org/keywords/chlordiazepoxide","display_name":"chlordiazepoxide","score":0.8190000057220459},{"id":"https://openalex.org/keywords/flurazepam","display_name":"flurazepam","score":0.996999979019165},{"id":"https://openalex.org/keywords/superior-cervical-ganglion","display_name":"superior cervical ganglion","score":0.8130000233650208},{"id":"https://openalex.org/keywords/gaba-response","display_name":"GABA response","score":0.5479999780654907},{"id":"https://openalex.org/keywords/beta-carbolines","display_name":"\u03b2-carbolines","score":0.7789999842643738},{"id":"https://openalex.org/keywords/ethyl-beta-carboline-3-carboxylate","display_name":"ethyl-beta-carboline-3-carboxylate","score":0.9380000233650208},{"id":"https://openalex.org/keywords/bicuculline","display_name":"bicuculline","score":0.7009999752044678},{"id":"https://openalex.org/keywords/pentobarbital","display_name":"pentobarbital","score":0.8220000267028809},{"id":"https://openalex.org/keywords/phenobarbital","display_name":"phenobarbital","score":0.9909999966621399},{"id":"https://openalex.org/keywords/gaba-a-receptor","display_name":"GABAA receptor","score":0.41100001335144043},{"id":"https://openalex.org/keywords/neuronal-excitability","display_name":"neuronal excitability","score":0.37700000405311584},{"id":"https://openalex.org/keywords/sympathetic-ganglia","display_name":"sympathetic ganglia","score":0.3440000116825104}],"concepts":[{"id":"https://openalex.org/C2780763569","wikidata":"https://www.wikidata.org/wiki/Q3639734","display_name":"Bicuculline","level":4,"score":0.9634862542152405},{"id":"https://openalex.org/C2778325228","wikidata":"https://www.wikidata.org/wiki/Q178566","display_name":"Chlordiazepoxide","level":3,"score":0.7718841433525085},{"id":"https://openalex.org/C168258287","wikidata":"https://www.wikidata.org/wiki/Q60147","display_name":"GABAA receptor","level":3,"score":0.6649141907691956},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6554703712463379},{"id":"https://openalex.org/C79636183","wikidata":"https://www.wikidata.org/wiki/Q5512770","display_name":"GABA receptor antagonist","level":5,"score":0.5940557718276978},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5406020283699036},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5264749526977539},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4395246207714081},{"id":"https://openalex.org/C2776175493","wikidata":"https://www.wikidata.org/wiki/Q210402","display_name":"Diazepam","level":2,"score":0.26020199060440063},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1902400553226471},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.16820812225341797},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.13602128624916077},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.11406514048576355}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001463","descriptor_name":"Barbiturates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001570","descriptor_name":"Benzodiazepinones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001640","descriptor_name":"Bicuculline","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002243","descriptor_name":"Carbolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002707","descriptor_name":"Chlordiazepoxide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005442","descriptor_name":"Flumazenil","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005479","descriptor_name":"Flurazepam","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005728","descriptor_name":"Ganglia, Sympathetic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011919","descriptor_name":"Rats, Inbred Strains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011963","descriptor_name":"Receptors, GABA-A","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1476-5381.1984.tb10119.x","doi":"https://doi.org/10.1111/j.1476-5381.1984.tb10119.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.1984.tb10119.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.1984.tb10119.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:1987195","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/1987195","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Pharmacol","raw_type":"Text"},{"id":"pmid:6091828","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6091828","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of pharmacology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1111/j.1476-5381.1984.tb10119.x","doi":"https://doi.org/10.1111/j.1476-5381.1984.tb10119.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.1984.tb10119.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.1984.tb10119.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.8199999928474426,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2087600102.pdf","grobid_xml":"https://content.openalex.org/works/W2087600102.grobid-xml"},"referenced_works_count":30,"referenced_works":["https://openalex.org/W1610957450","https://openalex.org/W1965666249","https://openalex.org/W1978342290","https://openalex.org/W1995964525","https://openalex.org/W1996066806","https://openalex.org/W1999400725","https://openalex.org/W2004267670","https://openalex.org/W2006538149","https://openalex.org/W2007500284","https://openalex.org/W2007911341","https://openalex.org/W2017363078","https://openalex.org/W2017659544","https://openalex.org/W2026336625","https://openalex.org/W2032468119","https://openalex.org/W2037299257","https://openalex.org/W2038873180","https://openalex.org/W2039884272","https://openalex.org/W2043598410","https://openalex.org/W2045537176","https://openalex.org/W2060497494","https://openalex.org/W2062506750","https://openalex.org/W2066486354","https://openalex.org/W2068213581","https://openalex.org/W2088606655","https://openalex.org/W2095588292","https://openalex.org/W2106438479","https://openalex.org/W2119308532","https://openalex.org/W2474544746","https://openalex.org/W4233475064","https://openalex.org/W4298407707"],"related_works":["https://openalex.org/W2008322352","https://openalex.org/W2112767091","https://openalex.org/W2417045428","https://openalex.org/W7100688000","https://openalex.org/W2261849664","https://openalex.org/W2270115585","https://openalex.org/W2069939206","https://openalex.org/W2104877311","https://openalex.org/W2039884272","https://openalex.org/W2029462562"],"abstract_inverted_index":{"The":[0,56,168,207,252],"effects":[1,255,275],"of":[2,14,19,40,58,73,83,89,95,107,115,142,166,223,227,248,254,256,263,276],"benzodiazepines":[3],"and":[4,33,45,162,182,216,260,282],"their":[5],"antagonists":[6],"on":[7,266,279],"the":[8,15,20,38,41,46,71,74,81,105,113,118,128,140,155,160,164,188,203,221,231,239,246,257,267,274],"responses":[9,39,72,94,156,189,204,232,240,268],"to":[10,30,43,76,101,150,157,190,198,205,233,241,269,273],"gamma-aminobutyric":[11],"acid":[12],"(GABA)":[13],"superior":[16],"cervical":[17],"ganglion":[18,42,75],"rat":[21],"were":[22,48,170,209,217],"examined":[23],"using":[24],"extracellular":[25],"recording.":[26],"Chlordiazepoxide":[27,68],"(1":[28],"microM":[29,63,79,103,181,244,250],"28.9":[31],"microM)":[32,152,215],"flurazepam":[34],"(145-725":[35],"nM)":[36],"increased":[37,70,238],"GABA":[44,59,77,90,131,158,242,270],"increases":[47,129],"antagonized":[49,171,210],"by":[50,120,134,137,172,211],"Ro":[51,121,123,173,212,228,264],"15-1788,":[52],"at":[53,179,196],"3.34":[54],"microM.":[55,86],"concentration":[57,88],"used":[60],"was":[61,271],"9.7":[62,102,235],"which":[64],"gave":[65],"half-maximal":[66],"responses.":[67],"similarly":[69],"38.8":[78,243],"in":[80,104,130,139,159,163,220,245,285],"presence":[82,141,161,222,247],"bicuculline":[84],"27.2":[85,249],"This":[87],"gave,":[91],"with":[92],"bicuculline,":[93],"a":[96],"similar":[97,272],"magnitude":[98],"as":[99],"those":[100],"absence":[106,165],"bicuculline.":[108,143,167,224,251],"Bicuculline":[109],"did":[110,125,184],"not":[111,126,185],"affect":[112,127],"actions":[114],"chlordiazepoxide":[116],"or":[117,136],"antagonism":[119],"15-1788.":[122],"15-1788":[124,174,213,229,265],"response":[132],"caused":[133],"pentobarbitone":[135],"phenobarbitone":[138],"Ethyl":[144],"beta-carboline-3-carboxylate":[145,193],"(beta":[146,194],"CCE)":[147],"(207":[148],"nM":[149,200],"1":[151],"significantly":[153,186,201],"decreased":[154,202,230],"decreases":[169,208],"(3.34":[175,214],"microM).":[176],"beta":[177],"CCE":[178],"2.1":[180],"above":[183],"change":[187],"GABA.":[191,206],"Methyl":[192],"CCM)":[195],"88":[197],"440":[199],"also":[218],"seen":[219],"High":[225],"concentrations":[226],"GABA,":[234],"microM,":[236],"but":[237],"pattern":[253],"benzodiazepines,":[258],"beta-carbolines":[259],"low":[261],"doses":[262],"these":[277],"compounds":[278],"seizure":[280],"threshold":[281],"anxiety-related":[283],"behaviour":[284],"vivo.":[286]},"counts_by_year":[{"year":2021,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}